Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs Biorestorative Therapies, Inc. (BRTX)

Aptevo Therapeutics Inc. and Biorestorative Therapies, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. is the larger, with a market value of $2.3M against $2.1M — 1.1× the size. Aptevo Therapeutics Inc. grew revenue faster over the last twelve months: 92.9% against −8.47%. Aptevo Therapeutics Inc. has the higher net margin (0.00% vs −3,089.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Biorestorative Therapies, Inc. leads on 10 and Aptevo Therapeutics Inc. on 7.

Valuation

Metric APVO BRTX Biotechnology median
P/E n/m n/m 10.60
P/S 0.11 3.67 9.40
P/B 0.25 0.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.18 0.15 0.66
EV/Sales (0.37) (5.84) 9.02
Earnings yield (4,659.10%) (1,445.95%) (32.88%)
Free cash flow yield (1,718.19%) (999.27%) (23.13%)

Profitability

Metric APVO BRTX Biotechnology median
Gross margin 0.00% 92.09% 68.51%
Operating margin 0.00% (3,974.66%) 0.00%
Net margin 0.00% (3,089.30%) 0.00%
Free cash flow margin 0.00% (3,302.04%) 0.00%
Return on equity (446.89%) (241.50%) (51.96%)
Return on assets (186.29%) (147.75%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO BRTX Biotechnology median
Revenue growth (TTM) 92.94% (8.47%) 6.76%
EPS growth (last fiscal year) 99.72% (36.21%) 29.88%
Revenue growth, 5-year CAGR (26.64%) 36.11% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO BRTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 2.35 4.97
Net debt to EBITDA 0.83 0.19 1.01

Dividend

Metric APVO BRTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric APVO BRTX Biotechnology median
Market cap 2.30m 2.09m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack